The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.
about
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionAntiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.Prevention and control of malaria in pregnancy - new threats, new opportunities?Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers.Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in -negative HIV-infected Malawian adults stabilized on antiretroviral therapyEffect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infection
P2860
Q36320042-43EF2D8B-60B6-4967-B6C6-FBCCD981C148Q37096787-7CC7DCCF-2053-4140-8322-6D60F86B3EA1Q37613241-A82A0CA1-2CCE-49AC-8045-712ABF682F39Q39038490-4BE324B7-5FAB-48D9-BAB9-90249E3A751BQ39099424-927BE681-7D9F-4BDF-97B2-ECD0E882A8CAQ46405195-C41FD35C-C17F-42D7-B944-BF49A078F5F7Q56339581-A94DBB10-EB3D-4109-91DC-139F3E4FC684Q56346858-5C22B603-DA4A-48F7-A08E-20F9F69E9474
P2860
The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The interaction between arteme ...... py in HIV-1 infected patients.
@ast
The interaction between arteme ...... py in HIV-1 infected patients.
@en
type
label
The interaction between arteme ...... py in HIV-1 infected patients.
@ast
The interaction between arteme ...... py in HIV-1 infected patients.
@en
prefLabel
The interaction between arteme ...... py in HIV-1 infected patients.
@ast
The interaction between arteme ...... py in HIV-1 infected patients.
@en
P2093
P2860
P50
P1476
The interaction between arteme ...... py in HIV-1 infected patients.
@en
P2093
J S Van der Walt
P2860
P2888
P356
10.1186/S12879-016-1345-1
P577
2016-01-27T00:00:00Z
P5875
P6179
1052962301